There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
1 response
1,875 views
0 reactions
|
by jazz710
07-21-2014, 03:08 PM
|
|||
|
1 response
1,640 views
0 reactions
|
by Olaf Blue
07-18-2014, 09:29 AM
|
|||
|
4 responses
4,368 views
0 reactions
|
by lorendarith
07-18-2014, 03:16 AM
|
|||
|
3 responses
4,549 views
0 reactions
|
07-18-2014, 02:10 AM
|
|||
|
3 responses
2,341 views
0 reactions
|
07-17-2014, 02:44 AM
|
|||
|
3 responses
2,280 views
0 reactions
|
07-16-2014, 06:56 PM
|
|||
|
2 responses
2,018 views
0 reactions
|
by jazz710
07-15-2014, 12:08 PM
|
|||
|
2 responses
2,106 views
0 reactions
|
07-14-2014, 06:36 PM
|
|||
|
0 responses
1,785 views
0 reactions
|
by KUHB
07-14-2014, 01:47 AM
|
|||
|
3 responses
1,736 views
0 reactions
|
by airun78
07-14-2014, 01:29 AM
|
No topics found.
-
Next-generation sequencing (NGS) is now central to outbreak investigations and antimicrobial resistance tracking. Through sophisticated...07-31-2026, 07:00 AM
-
The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.
This convergence of genetics, immunology, and computation...09-01-2026, 05:41 AM -
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM
